The stock price’s performance over the year has been unpredictable, resulting in a mix of pessimistic and optimistic outlooks among investors. Year to date metric has recorded a loss of -89.88%.However, over the last six months, we can see a stronger performance of -57.84%. Over the last 30 days, the price of VTAK has leaped by -29.10%. And in the last five days, it has fallen by -20.97%.
Catheter Precision Inc’s market performance has been unstable in recent times.
52-week price history of VTAK Stock
Analyzing a stock’s 52-week high and low prices can offer important information about its present condition and future outlook. Catheter Precision Inc’s current trading price is -93.05% away from its 52-week high, while its distance from the 52-week low is 14.57%. The stock’s price range during this period has varied between$0.15 and $2.49. The Catheter Precision Inc’s shares, which operate in the Healthcare, saw a trading volume of around 1.19 million for the day, a figure considerably lower than their average daily volume of 14.39 million over last three months.
Market Capitalization vs. Financial Performance: A Comparative Study
Catheter Precision Inc (VTAK) has experienced a quarterly decline of -35.71% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 2.18M and boasts a workforce of 22 employees.
Combining Moving Average and Trading Volume Data for Better Market Insight
Based on Barchart.com data, the company’s moving average over the 100-day period was 0.2847, with a change in price of -0.1630. Similarly, Catheter Precision Inc recorded 9,146,392 in trading volume during the last 100 days, posting a change of -48.51%.
VTAK’s Debt-to-Equity Ratio Cause for Concern? An In-Depth Look
The debt-to-equity (D/E) ratio is a significant metric that provides insights into a company’s financial state and market presence. By dividing a company’s current liabilities by its shareholders’ equity, the D/E ratio depicts the extent of debt used by a company to fund its assets relative to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for VTAK stands at 1.53. Similarly, the long-term debt-to-equity ratio is also 1.31.
VTAK Stock Stochastic Average
As of today, Catheter Precision Inc’s raw stochastic average for the last 50 days stands at 3.26%. This is a decline compared to the raw stochastic average of the previous 20 days, which was noted at 20.18%. Furthermore, the company’s Stochastic %K and %D values for the past 20 days were 8.91% and 7.44%, respectively.
